Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
Italy
/
Healthcare
Create a narrative
DiaSorin
BIT:DIA Community
1
Narratives
written by author
0
Comments
on narratives written by author
7
Fair Values set
on narratives written by author
Create a narrative
DiaSorin
Popular
Undervalued
Overvalued
DiaSorin
WA
Analyst Price Target
Consensus Narrative from 12 Analysts
MeMed, LIAISON PLEX, And Global Expansion Set To Boost Revenue And Earnings Growth
Key Takeaways Strong hospital strategy and new product offerings in the U.S. could drive significant revenue growth and new hospital additions. Expansion in non-European primary markets and new diagnostic tests are expected to contribute to sustained revenue and portfolio enhancement.
View narrative
€109.71
FV
10.6% undervalued
intrinsic discount
7.52%
Revenue growth p.a.
Set as Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
1 day ago
author updated this narrative
Your Valuation for
DIA
DiaSorin
Your Fair Value
€
Current Price
€98.06
13.6% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
2b
2015
2018
2021
2024
2025
2027
2030
Revenue €1.7b
Earnings €266.0m
Advanced
Set as Fair Value